Docosahexaenoic Acid Supplementation Alters Key Properties of Cardiac Mitochondria and Modestly Attenuates Development of Left Ventricular Dysfunction in Pressure Overload-Induced Heart Failure

PURPOSE: Supplementation with the n3 polyunsaturated fatty acid docosahexaenoic acid (DHA) is beneficial in heart failure patients, however the mechanisms are unclear. DHA is incorporated into membrane phospholipids, which may prevent mitochondrial dysfunction. Thus we assessed the effects of DHA su...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cardiovasc Drugs Ther
Main Authors: Dabkowski, Erinne R., O’Connell, Kelly A., Xu, Wenhong, Ribeiro, Rogerio F., Hecker, Peter A., Shekar, Kadambari Chandra, Stanley, William C., Daneault, Caroline, Rosiers, Christine Des
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4364545/
https://ncbi.nlm.nih.gov/pubmed/24013804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10557-013-6487-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados